Clinical trial
The Use of Botulinum Toxin-A in Two-stage Tissue Expander/Implant Breast Reconstruction: A Prospective, Randomized, Double-Blind Placebo Controlled Trial
NCT01427400 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of Botulinum Toxin-A in Two-stage Tissue Expander/Implant Breast Reconstruction: A Prospective, Randomized, Double-Blind Placebo Controlled Trial
- Lead sponsor
- University of British Columbia
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 31, 2011
- Completion date
- December 31, 2017
- Enrollment
- 128 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.